Mehrdad Nikfarjam

Intraductal tubulopapillary neoplasm.

Catherine Yu, Julie Lokan, Louise Jackett, Mehrdad Nikfarjam, Christopher Mills

Journal article  |  2022  |  BMJ Case Rep

A man aged above 70 years old with a medical history of ulcerative colitis presented with unintentional weight loss. A pancreatic ..

Prospective multicentre randomised controlled trial of the effect of Braun Enteroenterostomy in the Reconstruction after Pancreaticoduodenectomy on delayed gastric emptying (DGE): protocol for the BERP study.

Saksham Gupta, Kai Brown, Natalie Lott, Rosemary Carroll, David Burnett, Mehrdad Nikfarjam

Journal article  |  2022  |  BMJ Open

INTRODUCTION: Despite advances in achieving low mortality rates with pancreaticoduodenectomy (PD), morbidity remains high. A key c..

The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma.

Yi Ma, Mehrdad Nikfarjam, Hong He

Journal article  |  2022  |  Cancer Lett

Pancreatic Ductal Adenocarcinoma (PDA) is one of the most lethal types of cancer with a dismal prognosis. KRAS mutation is a commo..

Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Marcus Yeow, Joseph J Zhao, Khi Yung Fong, Joel Wong, Alvin Yong Hui Tan, Juinn Huar Kam, Mehrdad Nikfarjam, Brian KP Goh, Tousif Kabir

Journal article  |  2022  |  World J Surg

BACKGROUND: An updated systematic review and meta-analysis was conducted to compare radiofrequency ablation (RFA) versus repeat he..

A mixed blessing for liver transplantation patients - Rapamycin.

Guang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, Xu-Yong Wei, Sun-Bin Ling, Kai Wang, Jian-Guo Wang, Shu-Sen Zheng, Mehrdad Nikfarjam, Xiao Xu

Journal article  |  2022  |  Hepatobiliary Pancreat Dis Int

BACKGROUND: Liver transplantation (LT) is an effective treatment option for end-stage liver disease. Mammalian target of rapamycin..

Gallbladder-associated ectopic liver tissue during cholecystectomy.

Wendell Zhang, Laurence Weinberg, Khashayar Asadi, Mehrdad Nikfarjam

Journal article  |  2022  |  ANZ J Surg

Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis.

Ashleigh R Poh, Megan O'Brien, David Chisanga, Hong He, David Baloyan, Jasmin Traichel, Christine Dijkstra, Michaël Chopin, Stephen Nutt, Lachlan Whitehead, Louis Boon, Ashleigh Parkin, Clifford Lowell, Marina Pajic, Wei Shi, Mehrdad Nikfarjam, Matthias Ernst

Journal article  |  2022  |  Cell Rep

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a low 5-year survival rate and is associated with poor respo..

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry.

Jordan Santucci, Mark Tacey, Benjamin Thomson, Michael Michael, Rachel Wong, Julia Shapiro, Ross Jennens, Kate Clarke, Sharon Pattison, Matthew Burge, Rob Zielinski, Mehrdad Nikfarjam, Sumitra Ananda, Lara Lipton, Peter Gibbs, Belinda Lee

Journal article  |  2022  |  Eur J Cancer

BACKGROUND: First-line palliative chemotherapy regimens in advanced pancreatic ductal adenocarcinoma (PDAC) have not been compared..

1308P Comparison of tumour size on outcomes for patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) receiving P-32 microparticles with standard-of-care chemotherapy (SoC CT)

P Ross, HS Wasan, D Croagh, M Nikfarjam, N Nguyen, M Aghmesheh, A Nagrial, D Bartholomeusz, A Hendlisz, T Ajithkumar, C Iwuji, DM Turner, D James, M Harris

Journal article  |  2022  |  Annals of Oncology

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population

Imogen Walpole, Belinda Lee, Jeremy Shapiro, Benjamin Thomson, Lara Lipton, Sumitra Ananda, Val Usatoff, Sue-Ann Mclachlan, Brett Knowles, Adrian Fox, Rachel Wong, Prasad Cooray, Matthew Burge, Kate Clarke, Sharon Pattison, Mehrdad Nikfarjam, Niall Tebbutt, Marion Harris, Adnan Nagrial, Rob Zielinski, et al.

Conference Proceedings  |  2022  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Background: Use of neoadjuvant (NA) chemotherapy is recommended when pancreatic ductal adenocarcinoma (PDAC) is borderline resecta..